<?xml version="1.0" encoding="UTF-8"?>
<p id="Par3">The most effective way to protect against influenza is through vaccination. However, the current vaccination approaches rely on achieving a good match between circulating viruses and the vaccine strains
 <sup>
  <xref ref-type="bibr" rid="CR3">3</xref>
 </sup>. Mismatches may occur because the circulating viruses rapidly accumulate mutations in genes encoding the major surface antigens hemagglutinin (HA) and neuraminidase (NA)
 <sup>
  <xref ref-type="bibr" rid="CR4">4</xref>
 </sup>. Challenges may also include the reassortment of viral gene segments between different viruses of human or zoonotic origin, which may lead to the emergence of totally new and highly pathogenic strains
 <sup>
  <xref ref-type="bibr" rid="CR5">5</xref>
 </sup>. An ideal ‘universal vaccine’ could resolve all these problems by eliciting broadly reactive immune responses targeting conserved epitopes shared by all influenza viruses
 <sup>
  <xref ref-type="bibr" rid="CR6">6</xref>,
  <xref ref-type="bibr" rid="CR7">7</xref>
 </sup>.
</p>
